Subcutaneous injections of vaccine adjuvant DEAE-dextran induce local sarcomas in mice.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects*; D000818:Animals; D002273:Carcinogens; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects*; D004357:Drug Synergism; D005021:Ethylamines / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced*; D007279:Injections, Subcutaneous; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009379:Neoplasms, Muscle Tissue / Q000139:chemically induced*; D009607:Nitrosourea Compounds / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000139:chemically induced; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D002273:Carcinogens; D003911:Dextrans; D005021:Ethylamines; D009607:Nitrosourea Compounds; D014765:Viral Vaccines